Dexiglu 5mg Tablet
Marketer
Fusion Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dexiglu 5mg Tablet
Glucodex 5mg tablets are indicated, either independently or as part of a combined regimen, for managing type 2 diabetes. Its action lowers elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Glucodex 5mg can be administered with or without food, consistently at the same time each day, as prescribed by your physician. Discontinuing use without medical guidance may lead to heightened blood sugar and potentially severe consequences, such as renal impairment and visual loss. This medication forms one element of a comprehensive diabetes management plan encompassing diet, physical activity, and weight management under professional supervision. Commonly reported side effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. The medication can induce fluid loss; sufficient hydration is therefore crucial. Practicing good hygiene can help prevent genital infections. Prior to commencing treatment, discuss any pre-existing renal or hepatic conditions, urinary tract infections, or diuretic usage with your doctor. Pregnant or lactating individuals should also seek medical counsel. Limit alcohol consumption while using this medication to minimize the possibility of adverse effects. Regular blood glucose monitoring is recommended during treatment.
Uses of Dexiglu 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dexiglu 5mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dexiglu 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Dexiglu 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dexiglu 5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dexiglu 5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Dexiglu 5mg Tablet works:
Glucodex 5mg tablets are used to treat diabetes. They function by facilitating the excretion of surplus glucose via the urine.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dexiglu 5mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dexiglu 5mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Dexiglu 5mg tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dexiglu 5mg tablets is likely inadvisable for individuals with impaired kidney function and should be omitted. Seek medical advice.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment can safely take Dexiglu 5mg tablets without requiring any modification to the prescribed dosage.
What if you forget to take Dexiglu 5mg Tablet :
Should you forget a Dexiglu 5mg Tablet dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dexiglu 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |



